Orthopediatrics (KIDS) Cash from Investing Activities (2016 - 2026)

Orthopediatrics' (KIDS) quarterly Cash from Investing Activities came in at -$3.8 million in Q1 2026, up 36.75% year-on-year from -$2.8 million in Q1 2025, and up 47.83% on a QoQ basis from -$7.3 million in Q4 2025.

Orthopediatrics (KIDS) Cash from Investing Activities (2016 - 2026) Analysis & Trends

Orthopediatrics (KIDS) has 11 years of Cash from Investing Activities data on file, last reported at -$3.8 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 36.75% year-over-year to -$3.8 million in Q1 2026; TTM through Mar 2026 was -$41.4 million, a 167.8% decrease from a year earlier, with the FY2025 full-year figure at -$43.6 million, down 231.48% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$3.8 million, up from -$7.3 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for KIDS reached as high as $32.3 million in Q1 2023 and fell as low as -$103.9 million in Q3 2022.
  • Historically, Cash from Investing Activities has averaged -$7.8 million across 5 years, with a median of -$3.7 million in 2024.
  • Across the five-year window, Cash from Investing Activities surged 355.09% in 2022 and tumbled 3351.33% in 2023, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$23.2 million in 2022, then surged by 177.16% to $17.9 million in 2023, then plunged by 113.46% to -$2.4 million in 2024, then plunged by 200.95% to -$7.3 million in 2025, then soared by 47.83% to -$3.8 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$3.8 million in Q1 2026, -$7.3 million in Q4 2025, and -$26.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -475.32 Mn
10 Orthopediatrics 468.25 Mn 454.01 Mn 43.39 Mn -3.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.79 Mn
Mar 31, 2026 -3.79 Mn
Dec 31, 2025 -7.26 Mn
Dec 31, 2025 -7.26 Mn
Sep 30, 2025 -26.84 Mn
Sep 30, 2025 -26.84 Mn
Jun 30, 2025 -3.55 Mn
Jun 30, 2025 -3.55 Mn
Mar 31, 2025 -5.99 Mn
Mar 31, 2025 -5.99 Mn
Dec 31, 2024 -2.41 Mn
Dec 31, 2024 -2.41 Mn
Sep 30, 2024 -26.77 Mn
Sep 30, 2024 -26.77 Mn
Jun 30, 2024 19.70 Mn
Jun 30, 2024 19.70 Mn
Mar 31, 2024 -3.68 Mn
Mar 31, 2024 -3.68 Mn
Dec 31, 2023 17.92 Mn
Dec 31, 2023 17.92 Mn